The clinical investigation of the curative effect about Nai-Lao-Kang combination with antituberculotics in MDR-TB
- Conditions
- multidrug resistance tuberculosis
- Registration Number
- ITMCTR2000003501
- Lead Sponsor
- Chongqing Zhihui Institute of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Patients meeting the mdr-ptb/rr-ptb diagnostic criteria;
2. Those who meet the criteria for syndrome differentiation of lung Yin deficiency in traditional Chinese medicine;
3. According to the purpose of the clinical trial and the characteristics of this type of disease, the subjects are
between 18 and 65 years old;
4. No obvious abnormalities were found in liver and kidney function, fasting blood glucose and electrocardiogram.
1. Pregnant or lactating women;
2. People with allergic constitution, or who are known to be allergic to any of the drugs (Chinese and western
medicine) used in the treatment scheme of this subject;
3. Patients with malignant tumors, pneumoconiosis, epilepsy and autoimmune diseases;
4. Patients with severe primary diseases such as liver, kidney, cardiovascular and cerebrovascular diseases, hematopoietic system and endocrine system;
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of curative effect of TCM syndrome;CT value (lesion repair area);
- Secondary Outcome Measures
Name Time Method Drug susceptibility to drug-resistant tuberculosis;